Frédérique Bard Ph.D.


Head of Biology

Frédérique Bard, Ph. D., brings over 25 years of Biotech and Pharma industry experience with a focus on Neurogenerative diseases. In this role, Dr. Bard will be responsible for Cell Biology, Pharmacology, and Biomarkers.

Prior to joining E-Scape, Dr. Bard was Senior Director at the Janssen Pharmaceutical Companies of Johnson & Johnson, where she held several positions including leader of Non-clinical Research at Janssen Alzheimer Immunotherapy. From 1989 to 2011, Dr. Bard held various roles of increasing responsibility within Research at Elan Pharmaceuticals. As Vice President Biology, she managed several functional areas that supported both small and large molecule drug discovery for Alzheimer's Disease, Multiple Sclerosis, and Parkinson's Disease. Dr. Bard received her Ph.D. in Cell Biology from the University of Paris, France.